These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 6446258

  • 1. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
    Ito A, Hirai K, Inoue M, Koga H, Suzue S, Irikura T, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.
    Nakamura S, Minami A, Katae H, Inoue S, Yamagishi J, Takase Y, Shimizu M.
    Antimicrob Agents Chemother; 1983 May; 23(5):641-8. PubMed ID: 6575721
    [Abstract] [Full Text] [Related]

  • 4. Antibacterial activity of norfloxacin.
    Norrby SR, Jonsson M.
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
    Guimaraes MA, Noone P.
    J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
    [Abstract] [Full Text] [Related]

  • 7. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R, Allocati N, Catamo G.
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [Abstract] [Full Text] [Related]

  • 8. Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties.
    Shimizu M, Takase Y, Nakamura S, Katae H, Minami A.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):132-8. PubMed ID: 810076
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
    Downs J, Andriole VT, Ryan JL.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound.
    Chartrand SA, Scribner RK, Weber AH, Welch DF, Marks MI.
    Antimicrob Agents Chemother; 1983 May; 23(5):658-63. PubMed ID: 6223577
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.
    Neu HC, Labthavikul P.
    Antimicrob Agents Chemother; 1982 Jul; 22(1):23-7. PubMed ID: 6214995
    [Abstract] [Full Text] [Related]

  • 12. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A.
    Arzneimittelforschung; 1983 Jul; 33(12):1623-7. PubMed ID: 6230083
    [Abstract] [Full Text] [Related]

  • 13. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G.
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [Abstract] [Full Text] [Related]

  • 14. [Antibacterial in-vitro activity of pipemidic acid and nalidixic acid (author's transl)].
    Peters G, Freiesleben H, Marre R, Metz H, Tannenberg H, Pulverer G.
    Dtsch Med Wochenschr; 1979 Jun 29; 104(26):946-8. PubMed ID: 110574
    [Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo antibacterial activity of AB206, a new naphthyridine derivative.
    Nagate T, Kurashige S, Mitsuhashi S.
    Antimicrob Agents Chemother; 1980 Feb 29; 17(2):203-8. PubMed ID: 7387143
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    Seibert G, Limbert M, Klesel N.
    Eur J Clin Microbiol; 1983 Dec 29; 2(6):548-53. PubMed ID: 6230226
    [Abstract] [Full Text] [Related]

  • 17. Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
    Forward KR, Harding GK, Gray GJ, Urias BA, Ronald AR.
    Antimicrob Agents Chemother; 1983 Oct 29; 24(4):602-4. PubMed ID: 6228193
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of enoxacin compared with norfloxacin and amikacin.
    van der Auwera P, de Moor G, Lacroix G, Mambour A, Rossion N, Schuyteneer F.
    Eur J Clin Microbiol; 1985 Feb 29; 4(1):55-8. PubMed ID: 3157568
    [Abstract] [Full Text] [Related]

  • 19. Comparison of the antibacterial activity of norfloxacin (MK 0366, AM 715), a new organic acid, with that of other orally absorbed chemotherapeutic agents.
    Gadebusch HH, Shungu DL, Weinberg E, Chung SK.
    Infection; 1982 Jan 29; 10(1):41-4. PubMed ID: 6461606
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A.
    Scand J Infect Dis; 1985 Jan 29; 17(1):91-4. PubMed ID: 3158070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.